Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

Michael O'Riordan

November 11, 2024

News Daily News

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Michael O'Riordan

December 20, 2022

News Daily News

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

L.A. McKeown

August 10, 2021

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

News Daily News

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

Michael O'Riordan

August 04, 2017

News Industry News

Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin

August 25, 2016

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Daily News

Method Chosen to Estimate Pre-PCI Kidney Function Matters

L.A. McKeown

June 29, 2015

News Conference News ACC 2014

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Yael L. Maxwell

April 03, 2014

News Daily News

Remote Postconditioning Reduces AKI in NSTEMI Patients

March 15, 2013

News Daily News

Saline Bests Bicarbonate for Preventing Contrast Nephropathy

L.A. McKeown

January 23, 2012

News Conference News

Novel Anticoagulants Showing Benefits in A-fib Subgroups

August 29, 2011

News Daily News

REMEDIAL II Published: New Therapy Prevents Contrast-Induced Kidney Damage

Caitlin E. Cox

August 19, 2011

News Daily News

Renal Dysfunction Takes Toll on Carotid Revascularization Outcomes

June 22, 2011

Advertisement

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Method Chosen to Estimate Pre-PCI Kidney Function Matters

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Remote Postconditioning Reduces AKI in NSTEMI Patients

Saline Bests Bicarbonate for Preventing Contrast Nephropathy

Novel Anticoagulants Showing Benefits in A-fib Subgroups

REMEDIAL II Published: New Therapy Prevents Contrast-Induced Kidney Damage

Renal Dysfunction Takes Toll on Carotid Revascularization Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content